[Abstract 1582 and Poster 175] Differences in Perceptions and Use of Remote Patient Monitoring Technology in Rural Cancer Programs

This is a visual representation of an online publication from the American Society of Clinical Oncology 2023 Annual Meeting, June 2 - 6, 2023.

Authors

David Penberthy¹, Caroline Offit², Christina Mangir³, Leigh Boehmer², Bellinda King-Kallimanis⁴, Ramy Sedhom⁵, Cardinale B. Smith⁶, Smit Patel⁷, Jeffrey Kendall⁸, Jeff Hunnicutt⁹, Amanda G. Dean Martin¹⁰, Erin Pierce¹¹, Anne Marie Rainey¹², Adam P. Dicker¹³, Karen Fecenko-Tacka²

¹Penn State Health, Hershey, PA; ²Association of Cancer Care Centers, Rockville, MD; ³Rhizome, LLC, Washington DC, DC; ⁴LUNGevity Foundation, Silver Spring, MD; ⁵Penn Medicine, Philadelphia, PA; ⁶Icahn School of Medicine at Mount Sinai, New York, NY; ⁷Digital Medicine Society, Boston, MA; ⁸University of Minnesota, Minneapolis, MN; ⁹Highlands Oncology Group, P.A., Fayetteville, AR; ¹⁰Banner MD Anderson Cancer Center, Gilbert, AZ; ¹¹Ochsner Medical Center, New Orleans, LA; ¹²Clearview Cancer Institute, Huntsville, AL; ¹³Thomas Jefferson University Methodist Hospital, Philadelphia, PA

Background

While the benefits and acceptability of remote patient monitoring (RPM) during cancer care are well documented, barriers to implementation and use of these digital technologies remain. Feasibility may be particularly restricted in rural settings. The Association of Cancer Care Centers (ACCC) surveyed U.S. cancer programs, patients with cancer and caregivers in various geographic settings to illuminate the current practice landscape and perceptions regarding the use of digital technologies to monitor patients for adverse events and collect patient reported outcomes (PROs).

See full abstract as well as a downloadable PDF in the Journal of Clinical Oncology (JCO).

View Abstract

See poster presented at the 2023 ASCO Annual Meeting. (You must sign in with your ASCO account username and password to access. Account set up is free.)

View Poster

Acknowledgements

ACCC would like to thank our project partners: LUNGevity and Digital Medicine Society (DiMe).

Funding

This project is supported by AstraZeneca.